← All companies
GLUE annual net income
Monte Rosa Therapeutics, Inc.
GLUE - CIK 0001826457
Market cap$1.40 B
Rank#2377
SEC filings352
Monte Rosa Therapeutics, Inc. net income by year
Monte Rosa Therapeutics, Inc. (GLUE) reported net income of -$38.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
GLUE net income 2020-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$38.60M | +46.9% |
| FY 2024 | -$72.70M | +46.3% |
| FY 2023 | -$135.35M | -24.7% |
| FY 2022 | -$108.50M | -46.7% |
| FY 2021 | -$73.96M | -106.1% |
| FY 2020 | -$35.88M | - |
Net Income of similar companies
Frequently asked questions
How much profit does Monte Rosa Therapeutics, Inc. make?
Monte Rosa Therapeutics, Inc. (GLUE) reported net income of -$38.60M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Monte Rosa Therapeutics, Inc.'s net income changed over time?
Between fiscal 2020 and fiscal 2025, Monte Rosa Therapeutics, Inc.'s net income declined from -$35.88M to -$38.60M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.